Data for Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma (Study ST000916)

(Analysis AN001496)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3F4
LPC(16:0) 0.6449 1.1285 0.9785 1.3134
LPC(18:0) 0.6642 1.2073 1.0099 1.1460
LPC(18:1) 0.8740 1.0590 0.9335 1.2028
LPC(18:2) 0.7776 0.9971 1.0142 1.2396
LPC(20:4) 0.7662 1.0356 1.0569 1.1404
LPE(16:0) 0.8835 0.9953 1.0908 0.9769
LPE(18:0) 0.7512 1.0471 1.0584 1.1308
LPE(18:1) 1.0706 0.9093 1.0342 0.9613
LPE(18:2) 1.0695 0.9441 0.9704 1.0380
LPE(20:4) 0.6294 1.0731 0.9942 1.3606
LPE(22:4) 0.7883 1.1468 0.9633 1.1433
LPE(22:5) 0.7569 1.0488 0.9530 1.3143
LPE(22:6) 0.6194 0.9676 1.0901 1.3216
LPI(18:0) 0.6513 0.6738 1.1464 1.5078
LPI(20:4) 0.6103 0.8190 1.1321 1.4199
PA(36:2) 0.8043 1.0524 1.0387 1.1035
PC(32:0) 1.4204 1.0852 0.7952 0.7787
PC(32:1) 0.9631 1.1332 0.9917 0.9019
PC(34:1) 0.9174 0.9977 1.0290 1.0470
PC(34:2) 0.8133 1.0737 1.0344 1.0701
PC(34:3) 0.6254 1.1603 1.1109 1.0499
PC(36:0e) 0.9693 0.8072 1.0828 1.1006
PC(36:1) 1.0114 0.9190 1.0278 1.0311
PC(36:1e) 0.7517 0.9159 1.1109 1.1905
PC(36:2) 0.9633 0.9549 1.0103 1.0776
PC(36:2e) 0.8459 0.9154 1.0587 1.1692
PC(36:3) 0.8663 1.0415 1.0209 1.0704
PC(36:4) 0.4920 1.1857 1.0782 1.2365
PC(36:4e) 0.8568 1.1066 1.0392 0.9716
PC(38:2) 1.3930 0.6244 1.1965 0.6003
PC(38:3) 0.6198 1.1233 1.1316 1.0623
PC(38:4) 0.5243 1.1602 1.1027 1.1840
PC(38:5) 0.6055 1.0862 1.1040 1.1731
PC(38:5e) 1.0210 1.0561 0.9918 0.9243
PC(38:6) 0.5248 1.0432 1.1199 1.2896
PC(40:5) 0.6755 1.0774 1.1263 1.0844
PC(40:6) 0.5456 1.0285 1.1609 1.2299
PC(42:5e) 0.7277 0.9523 1.1150 1.1374
PE(34:1) 0.8267 1.0158 0.9869 1.2091
PE(34:2) 0.8570 0.9324 1.1064 1.0536
PE(36:1) 1.0685 1.0219 0.8513 1.1648
PE(36:1p) 1.0714 1.0255 0.9796 0.9232
PE(36:2) 1.0634 0.9112 0.9891 1.0499
PE(36:2p) 1.2841 0.9602 1.0273 0.6629
PE(36:3) 1.2539 0.7903 0.9754 0.9929
PE(36:3p) 0.9470 1.0300 1.0789 0.8831
PE(36:4) 0.6302 0.9701 1.1383 1.2179
PE(36:4p) 0.6888 1.2433 1.1654 0.7782
PE(38:4) 0.5414 1.2372 1.0520 1.1658
PE(38:4p) 0.6165 1.3322 1.1849 0.7231
PE(38:5) 0.6370 1.1239 1.0896 1.1180
PE(38:5p) 0.6695 1.2530 1.2007 0.7252
PE(38:6) 0.5147 1.0611 1.1620 1.2037
PE(40:4p) 0.5972 1.3262 1.1246 0.8629
PE(40:5) 0.6007 1.1456 0.9451 1.3751
PE(40:5p) 0.6080 1.1864 1.2104 0.8581
PE(40:6) 0.4916 1.1720 1.0755 1.2580
PE(40:6p) 0.6740 1.2795 1.1501 0.7810
PI(32:1) 0.8163 1.4252 0.9238 0.8493
PI(34:1) 1.0789 1.1533 0.8935 0.9211
PI(34:2) 0.7932 1.1720 0.9600 1.1139
PI(36:1) 1.3356 0.9928 0.8506 0.8862
PI(36:2) 1.0432 0.9873 0.9581 1.0404
PI(36:3) 1.2619 0.9686 0.8962 0.9181
PI(36:4) 0.8532 1.0836 0.9786 1.1134
PI(38:3) 0.7113 1.1206 0.9921 1.2121
PI(38:4) 0.6243 1.0913 1.0115 1.3136
PI(38:5) 0.9024 1.0392 0.9629 1.1363
PI(40:4) 0.6917 1.1788 1.0948 0.9794
PI(40:5) 0.6823 1.1621 1.0462 1.0988
PI(40:6) 0.7168 1.0951 1.0704 1.0930
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Diagnosis:Cirrhosis
F2Diagnosis:NASH
F3Diagnosis:Normal
F4Diagnosis:Steatosis
  logo